ストックスクリーナーアプリを入手
0.6432
1.77%
0.0112
アフターアワーズ：
.64
-0.0032
-0.50%
Iridex Corp (IRIX) 最新ニュース
IRIX News Sentiment - Investing.com Canada
IRIDEX (IRIX) CFO buys 7,900 more shares - Stock Titan
IRIDEX (IRIX) CFO adds 2,354 shares in open-market buy - Stock Titan
CFO now holds 175,052 shares after Iridex Corp (IRIX) stock buy - Stock Titan
IRIDEX Received Notice of Noncompliance - TradingView
IRIDEX (NASDAQ:IRIX): What Is Driving Penny Stock Attention? - Kalkine Media
IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15% - Yahoo Finance
IRIDEX (IRIX) Latest Quarter: The EPS Result Is Below Expectation in the Current Update; Latest Reaction: Shares Close 0.81% Lower at the CloseOperating Margin Analysis - dars.gov.et
IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ... - Yahoo Finance
IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 - GuruFocus
IRIX Looks 45.3% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Earnings call transcript: IRIDEX misses Q2 2026 estimates as cash flow turns positive - Investing.com South Africa
IRIDEX Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Is IRIDEX Corp (IRIX) Positioned for Growth After Q2 Earnings Mi - GuruFocus
IRIDEX Q2 Revenue Falls 7% as Retina Weakness Offsets Glaucoma Growth - Minichart
Form 8K IRIDEX Corporation For: 18 August By Investing.com - Investing.com Canada
Full Transcript: Iridex Q2 2026 Earnings Call - Benzinga
IRIDEX Corp reports results for the quarter ended June 30Earnings Summary - TradingView
IRIDEX CORP Q2 2026: Revenue $12.6M, EPS $(0.07) — 10-Q Summary - TradingView
IRIDEX (IRIX) glaucoma sales rise as retina revenue falls - Stock Titan
IRIDEX earnings missed by $0.05, revenue fell short of estimates - Investing.com
Iridex Reports Q2 2026 Revenue $12.6M, Net Loss $1.3M; Cyclo G6 Probe Growth Boosts Glaucoma Sales - TradingView
Iridex falls short on Q2 revenue and earnings expectations - Investing.com
Iridex falls short on Q2 revenue and earnings expectations By Investing.com - Investing.com Australia
IRIDEX ($IRIX) Releases Q2 2026 Earnings - Quiver Quantitative
Iridex Latest Results: FY26 sales guidance affirmed at $51M-$53M, below est - scanx.trade
Iridex Q2 revenue misses estimate as loss widens to $0.07 - scanx.trade
Iridex: Q2 Earnings Snapshot - marketscreener.com
Iridex Reports Second Quarter 2026 Financial Results - GlobeNewswire
Iridex (NASDAQ:IRIX): Why Is Ophthalmic Systems And Procedure Activity in Focus Today? - Kalkine Media
IRIX|IRIDEX Corp|Price:0.880|Chg%:+0.024 - TradingKey
IRIDEX Corp (IRIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRIDEX Corp (IRIX) Stock News Today - TradingKey
Iridex schedules Q2 business update after Aug. 18 close - Stock Titan
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 - GlobeNewswire
IRIX Faces Continued Pressure Near Key Support Levels – IRIDEX Corporation (IRIX) at $0.86Wyckoff Distribution - dars.gov.et
IRIDEX Corp (IRIX) Institutional Confidence - TradingKey
IRIX|IRIDEX Corp|Price:0.889|Chg%:-0.002 - TradingKey
IRIDEX Corp (IRIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRIDEX Corp (IRIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRIDEX Corp (IRIX) Cash Flow - TradingKey
IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRIX|IRIDEX Corp|Price:0.783|Chg%:-0.147 - TradingKey
IRIDEX Corp (IRIX) Income Statement - TradingKey
IRIDEX Corp (IRIX) Earnings Date & Reports & Earnings News - TradingKey
IRIDEX Corp (IRIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRIDEX Corp (IRIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRIX|IRIDEX Corp|Price:0.930|Chg%:+0.050 - TradingKey
Iridex expands EyeProGPO offering with EndoProbe handpieces - Investing.com
More Than 4,300 EyeProGPO Members Gain Preferred EndoProbe Pricing - Stock Titan
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering - GlobeNewswire
Iridex Board Warns of Legal Risks in Stealth Proxy Campaign by Major Shareholder Novel Inspiration - minichart.com.sg
Form 4 IRIDEX Corporation For: 14 July By Investing.com - Investing.com Nigeria
IRIDEX CORP (IRIX) grants CFO 30K RSUs and 170K options - Stock Titan
Form 13D/A IRIDEX CORP For: 13 July By Investing.com - Investing.com Nigeria
0.26%
0.38%
大文字化:
|
ボリューム (24 時間):